A phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic Pancreatic Cancer

Projektdetaljer

Beskrivelse

An investigator initiated clinical trial of combined immunotherapy (PD1-inhibitor) and irreversible electroporation in patients with metastatic pancreatic cancer.
The aim is to examine the efficacy and safety of the combined treatment.
Kort titelElectroporation Potentiated Immunotherapy in Cancer – 1.st study
AkronymEPIC-1
StatusIgangværende
Effektiv start/slut dato01/01/202131/12/2025